{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T07:30:03Z","timestamp":1769067003861,"version":"3.49.0"},"reference-count":21,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p> Prolonged intravenous (IV) antibiotic therapy may not be optimal for people who inject drugs (PWID) with infective endocarditis (IE) due to unique social and medical needs. The role of partial IV antibiotic therapy with continued oral (PO) antibiotic therapy is unclear. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p> A systematic review was performed using EMBASE and MEDLINE databases. Included studies compared PO to IV antibiotic treatment for IE in PWID. <\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p> Four studies met eligibility. Observational studies included full IV treatment groups and partial IV, partial PO treatment groups for severe injection-related infections. PWID with IE comprised 41.0%\u201364.7% of the study populations but outcomes specific to IE were not separately reported. All-cause 90-day readmission rates were comparable between the IV treatment group (27.9%\u201331.5%) and partial IV, partial PO treatment group (24.8%\u201332.5%). Ninety-day mortality was non-significantly different between IV treatment (4.9%\u201310.7%) and partial IV, partial PO treatment groups (2.4%\u201313.0%). One small randomized clinical trial compared IV oxacillin or vancomycin with gentamicin to PO ciprofloxacin plus rifampin. The cure rates were 91% and 90%, respectively. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p> There is limited evidence comparing IV treatment to partial IV, partial PO antibiotic treatment in PWID with IE. Observational studies suggest that PO antibiotic therapy after initial IV treatment may be equivalent to full IV treatment alone within specific parameters, but randomized trials are needed to inform recommendations. Substantial clinical and social benefits for PWID and advantages for the health care system will result if PO treatment strategies with equal efficacy can be implemented. <\/jats:p><\/jats:sec>","DOI":"10.3138\/jammi-2023-0013","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T05:41:42Z","timestamp":1703137302000},"page":"253-261","source":"Crossref","is-referenced-by-count":3,"title":["Partial oral versus full intravenous antibiotic treatment of endocarditis in people who inject drugs: A systematic review"],"prefix":"10.3138","volume":"8","author":[{"given":"Amy","family":"Brown","sequence":"first","affiliation":[{"name":"Libin Cardiovascular Institute, Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hallie L","family":"Jefferson","sequence":"additional","affiliation":[{"name":"Libin Cardiovascular Institute, Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Daley","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Memorial University, St. John's, Newfoundland and Labrador, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William DT","family":"Kent","sequence":"additional","affiliation":[{"name":"Libin Cardiovascular Institute, Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Webster","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Dalhousie University, Saint John, New Brunswick, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corey","family":"Adams","sequence":"additional","affiliation":[{"name":"Libin Cardiovascular Institute, Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"issue":"14","key":"r1","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1161\/CIR.0000000000001090","volume":"146","author":"Baddour LM","year":"2022","journal-title":"Circ"},{"issue":"15","key":"r2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","volume":"132","author":"Baddour LM","year":"2015","journal-title":"Circ"},{"key":"r3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2334-14-140","volume":"14","author":"Al-Omari A","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"10","key":"r4","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1093\/cid\/ciaa365","volume":"71","author":"Marks LR","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"r5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.idc.2020.06.010","volume":"34","author":"Serota DP","year":"2020","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"r6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/cid\/ciac714","volume":"76","author":"Wildenthal JA","year":"2023","journal-title":"Clin Infect Dis"},{"key":"r7","author":"Wells GA","year":"2014","journal-title":"Ottawa Hospital Research Institute"},{"key":"r8","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"Higgins JPT","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"r9","doi-asserted-by":"crossref","first-page":"ofab633","DOI":"10.1093\/ofid\/ofab633","volume":"9","author":"Lewis S","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"r10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9343(96)00070-8","volume":"101","author":"Heldman AW","year":"1996","journal-title":"Am J Med"},{"issue":"5","key":"r11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","volume":"380","author":"Iversen K","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"r12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.idc.2020.06.004","volume":"34","author":"Schranz A","year":"2020","journal-title":"Infect Dis Clin North Am"},{"issue":"8","key":"r13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.tcm.2019.11.007","volume":"30","author":"Sanaiha Y","year":"2020","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"r14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.amjmed.2019.08.022","volume":"133","author":"El-Dalati S","year":"2020","journal-title":"Am J Med"},{"issue":"4","key":"r15","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1503\/cmaj.180694","volume":"191","author":"Weir MA","year":"2019","journal-title":"CMAJ"},{"issue":"5","key":"r16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cjco.2020.05.002","volume":"2","author":"Mosseler K","year":"2020","journal-title":"CJC Open"},{"issue":"3","key":"r17","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cid\/ciz869","volume":"71","author":"Straw S","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"r18","doi-asserted-by":"crossref","first-page":"e220541","DOI":"10.1001\/jamanetworkopen.2022.0541","volume":"5","author":"Adams JW","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2324","key":"r19","doi-asserted-by":"crossref","first-page":"w20259","DOI":"10.4414\/smw.2020.20259","volume":"150","author":"Aur\u00e9lien EM","year":"2020","journal-title":"Swiss Med Wkly"},{"key":"r20","unstructured":"National Library of Medicine (US). Staphylococcus Aureus network adaptive platform trial (SNAP); 2002. Identifier NCT05137119. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05137119."},{"issue":"32","key":"r21","volume":"5","author":"Murdoch B","year":"2016","journal-title":"Bio\u00e9thique Online"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2023-0013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:21:31Z","timestamp":1760124091000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2023-0013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12,1]]}},"alternative-id":["10.3138\/jammi-2023-0013"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2023-0013","relation":{},"ISSN":["2371-0888","2371-0888"],"issn-type":[{"value":"2371-0888","type":"print"},{"value":"2371-0888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}